Lipoprotein metabolism following gastroplasty in obese women

References

• Drenick E J, Bale G S, Seltzer F. Excessive mortality and causes of death in morbidly obese men. JAMA 1980; 243: 443–5
   PubMed Web of Science ®Google Scholar
• Hubert H B, Feinleib M, McNamara P M, Castelli W P. Obesity as an independent risk factor for cardiovascular disease: a twenty-six year old follow-up of Framingham Heart Study participants. Circulation 1983; 67: 968–77
   PubMed Web of Science ®Google Scholar
• Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: a 13 year follow up of participants in the study of men born in 1913. Br Med J 1984; 288: 1401–4
   PubMed Web of Science ®Google Scholar
• Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up participants in the population study of women in Gothenburg, Sweden. Br Med J 1984; 289: 1261–3
   PubMed Web of Science ®Google Scholar
• McFarland R J, Gazet J C, Pilkington T RE. A 13-year review of jejunoileal bypass. Br J Surg 1985; 72: 81–7
   PubMed Web of Science ®Google Scholar
• Griffin W O, Jr, Bivius B A, Bell R M. The decline and fall of the jejunoileal bypass. Surg Gynecol Obstet 1983; 157: 301–8
   PubMedGoogle Scholar
• Linner J H. Surgery for Morbid Obesity. Springer Verla, Berlin 1984; 1–208
   Google Scholar
• Wadden T A, Stunkard A J, Brownell K D. Very low calorie diets. Their efficacy, safety and future. Am Intern Med 1983; 99: 675–84
   Web of Science ®Google Scholar
• Kannel W B, Gordon T, Castelli W P. Obesity, lipids and glucose intolerance. The Framingham Study. Am J Clin Nutr 1979; 32: 1238–45
   PubMed Web of Science ®Google Scholar
• Hoffer L J, Bistrian B R, Young V R, Blackburn G L, Matthews D E. Metabolic effects of very low calorie weight reduction diets. J Clin Invest 1984; 73: 750–8
   PubMed Web of Science ®Google Scholar
• van Itallie T B. Obesity, genetics and ponderal set points. Clin Neuropharmacol 1988; 11(Suppl 1)91–7
   Google Scholar
• Hudson J J, Harrison G P, Jones J M, Laffer P S, Hudson M S, Melby J S. Hypothalamic-pituitary axis hyper activity in bulimina. Psychiatry Res Commun 1983; 8: 111–7
   Google Scholar
• Sims E AH, Danforth E, Jr, Horton E S, Bray G A, Glennon J A, Salans L B. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 1973; 29: 457–96
   PubMedGoogle Scholar
• Zumoff B. Hormonal abnormalities in obesity. Acta Med Scand 1988, Suppl. 723: 153–60
   PubMedGoogle Scholar
• Koltermann O G, Insel J, Saekow M, Olefsky J M. Mechanisms of insulin resistance in human obesity. Evidence for receptor and postreceptor defects. J Clin Invest 1980; 65: 1272–84
   PubMed Web of Science ®Google Scholar
• Mancini M, Contaldo F, Mattioli P L, Caprio S, Postiglione A, Rivellese A. Metabolic abnormalities associated with obesity: effects of weights loss. Obesity: Pathogenesis and Treatment, G Enzi, G Crepaldi, G Pozza, A E Renolds. Academic Press, London 1981; 271–81
   Google Scholar
• Grundy S M, Mok H Y, Zech L, Steinberg D, Berman M. Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. J Clin Invest 1979; 63: 1274–83
   PubMed Web of Science ®Google Scholar
• Hanefeld M, Mancini M. Obesity. Atherosclerosis, Biology and Clinical Science, A G Olsson. Churchill Livingstone, Edinburgh 1987; 437–44
   Google Scholar
• Mason E. Vertical banded gastroplasty for obesity. Arch Surg 1982; 117: 701–6
   PubMed Web of Science ®Google Scholar
• Burke B S. The dietary history as a tool in research. J Am Dietet Ass. 1947; 23: 1041–6
   Google Scholar
• Arnquist H, Olsson P O, von Schenck H. Free and total insulin as determined after precipitation with polyethylene glycol. Clin Chem 1987; 33: 93–6
   PubMed Web of Science ®Google Scholar
• Heding L G. Radioimmunological determinations of human C-peptide in serum. Diabetologia 1975; 11: 541–8
   PubMed Web of Science ®Google Scholar
• von Schenck H. Radioimmunoassay of glucagon. Methods in Diabetes Research, J Larner, S Pohl. John Wiley and Sons Inc. 1984; Volume I: 327–45, Laboratory Methods, Part B.
   Google Scholar
• Wallentin L, Fahreaus L. HDL, and HDL2 determination by a combined ultracentrifugation and precipitation procedure. Clin Chim Acta 1982; 116: 199–208
   Web of Science ®Google Scholar
• Wallentin L, Vikrot O. Evaluation of an in vitro assay of lecithin:cholesterol acyl transfer rate in plasma. Scand J Clin Lab Invest 1975; 35: 661–7
   PubMed Web of Science ®Google Scholar
• Hoist J J. Glucagon in obesity. Glucagon, P J Lefèe. Springer Verlag, Berlin Heidelberg 1983; Vol II: 507–21
   Google Scholar
• Connor W E. The relationship of hyperlipoproteinemia to atherosclerosis-the decisive role of dietary cholesterol and fat. The Biochemistry of Atheroslcerosis, A M Scanu, R W Wissler, G S Getz. Marcel Dekker, New York 1979; 371–418
   Google Scholar
• Wallentin L, Sköldstam L. Lipoproteins and cholesterol esterification rate in plasma during a 10-day modified fast in man. Am J Clin Nutr 1980; 33: 1925–31
   PubMed Web of Science ®Google Scholar
• Wallentin L, Sundin B. HDL2 and HDL3 lipid levels in coronary artery disease. Atherosclerosis 1985; 59: 131–26
   Web of Science ®Google Scholar
• Wallentin L, Angelin B, Einarsson K, Leijd B. Lecithin:cholesterol acyl transfer rate in plasma and its relations to lipoprotein concentrations and to kinetics of bile acids and triglycerides in hyperlipoproteinemic subjects. Scand J Clin Lab Invest 1978; 38(Suppl 150)103–10
   Google Scholar
• Angelin B, Einarsson K, Leijd B, Wallentin L. Plasma cholesterol esterification rate in type IV hyperlipoproteinemia. J Lab Clin Med 1981; 97: 502–10
   PubMed Web of Science ®Google Scholar
• Angelin B, Einarsson K, Leijd B, Wallentin L. Plasma cholesterol esterification rate in hyperlipoproteinaemia: Relation to cholesterol elimination. Scand J Clin Lab Invest 1988; 48: 481–7
   PubMed Web of Science ®Google Scholar
• Wallentin L. Lecithin: cholesterol acyl transfer rate in plasma and its relation to lipid and lipoprotein concentrations in primary hyperlipidemia. Atherosclerosis 1977; 26: 233–48
   PubMed Web of Science ®Google Scholar
• Wallentin L. Lecithinxholesterol acyl transfer rate and high density lipoproteins in plasma during dietary and clofibrate treatment of hypertriglyceridemic subjects. Atherosclerosis 1978; 31: 41–52
   PubMed Web of Science ®Google Scholar